Ratio Therapeutics is innovating in the field of cancer treatment with its advanced platforms, TRILLIUM™ and MACROPA™, which enhance radioligand pharmacokinetics and streamline the production of actinium-225. Focused on targeted radioligand therapy, we are committed to developing novel therapeutic candidates that aim to improve cancer patients' lives without compromising their quality of life.
No jobs found
Try different keywords or remove some filters.
Or create a free account and we’ll email you when new jobs match what you’re looking for.
Create a free account
Searching